Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

OBJECTIVES: To determine the clinical and cost-effectiveness of different classes of antipsychotic drug treatment in people with schizophrenia responding inadequately to, or having unacceptable side-effects from, their current medication. DESIGN: Two pragmatic, randomised controlled trials (RCTs) we...

Full description

Bibliographic Details
Main Authors: Lewis, S, Davies, L, Jones, P, Barnes, T, Murray, R, Kerwin, R, Taylor, D, Hayhurst, K, Markwick, A, Lloyd, H, Dunn, G
Format: Journal article
Language:English
Published: 2006